UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Treating cancer in older and oldest old patients

Current pharmaceutical design, 2015-01, Vol.21 (13), p.1699

2015

Link zum Volltext

Verfügbarkeit prüfen

Founder mutations in BRCA1 and BRCA2 genes

Annals of oncology, 2007-06, Vol.18 (suppl-6), p.vi93-vi98

2007

Link zum Volltext

Verfügbarkeit prüfen

6563 POSTER Chromogranine a (CG-A) Plus Vascular Endothelial Growth Factor (VEGF) as Predicting Factors (PF) of Sorafenib (SFB) Treatment of Multifocal Hepatocellular Carcinoma (M-HCC) in Elderly Patients

European journal of cancer (1990), 2011, Vol.47, p.S460-S460

2011

Link zum Volltext

Verfügbarkeit prüfen

Sorafenib (SFB) flat dose (FD) in frail elderly patients (FEPts) with Child–Pugh Advanced Hepatocellular Carcinoma (AHCC): Two year

Journal of geriatric oncology, 2012-10, Vol.3, p.S70-S71

2012

Link zum Volltext

Verfügbarkeit prüfen

Cancer in the older person

Cancer treatment reviews, 2005-08, Vol.31 (5), p.380-402

2005

Link zum Volltext

Verfügbarkeit prüfen

Assessment and treatment of elderly people with cancer: Italian (AIOM–SIGG) onco-geriatric survey results

Journal of geriatric oncology, 2012-10, Vol.3, p.S71-S72

2012

Link zum Volltext

Verfügbarkeit prüfen

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

The New England journal of medicine, 2009-08, Vol.361 (8), p.766-776

2009

Link zum Volltext

Verfügbarkeit prüfen

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

British journal of cancer, 2001-05, Vol.84 (9), p.1166-1171

2001

Link zum Volltext

Verfügbarkeit prüfen

4017 Antiangiogenetic drugs in combination with irinotecan (IRI) and capecitabine (XEL) in ACRC elderly patients: first data about safety and efficacy

European journal of cancer supplements, 2009, Vol.7 (2), p.220-220

2009

Link zum Volltext

Verfügbarkeit prüfen

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

The lancet oncology, 2012-04, Vol.13 (4), p.420-432

2012

Link zum Volltext

Verfügbarkeit prüfen

Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e14086-e14086

2011

Link zum Volltext

Verfügbarkeit prüfen

Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.3552-3552

2010

Link zum Volltext

Verfügbarkeit prüfen

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

Anti-cancer drugs, 1993-08, Vol.4 (4), p.443-446

1993

Link zum Volltext

Verfügbarkeit prüfen

Impact of VEGF and CgA as new predictive tools in management of elderly hormone-refractory prostate cancer (HRPC) patients

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e16070-e16070

2009

Link zum Volltext

Verfügbarkeit prüfen

Management of breast cancer in the older woman

Cancer control, 2001-09, Vol.8 (5), p.431-441

2001

Link zum Volltext

Verfügbarkeit prüfen

Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.19586-19586

2007

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a combined treatment schedule with fulvestrant (F) and capecitabine (C) in elderly advanced breast cancer patients

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.12003-12003

2008

Link zum Volltext

Verfügbarkeit prüfen

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Breast cancer research and treatment, 2012-01, Vol.131 (1), p.295-306

2012

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect?

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.13133-13133

2006

Link zum Volltext

Verfügbarkeit prüfen

Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10556-10556

2006

Link zum Volltext

Verfügbarkeit prüfen

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.1578-1578

2005

Link zum Volltext

Verfügbarkeit prüfen

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Clinical trials (London, England), 2009-06, Vol.6 (3), p.272-287

2009

Link zum Volltext

Verfügbarkeit prüfen

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5- fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.9624-9624

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(96)

Publikationsform

Artikel
(109)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Humans
(41)
Life Sciences & Biomedicine
(41)
Aged
(20)
Female
(19)
Oncology
(19)
Male
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Middle Aged
(15)
Proteins
(11)
Hematology, Oncology And Palliative Medicine
(10)
Tumors
(10)
Adult
(9)
Proteomics
(8)
Antineoplastic Agents
(7)
Chemotherapy
(7)
Pharmacology. Drug Treatments
(7)
Antineoplastic Agents - Therapeutic Use
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Treating cancer in older and oldest old patients

Founder mutations in BRCA1 and BRCA2 genes

6563 POSTER Chromogranine a (CG-A) Plus Vascular Endothelial Growth Factor (VEGF) as Predicting Factors (PF) of Sorafenib (SFB) Treatment of Multifocal Hepatocellular Carcinoma (M-HCC) in Elderly Patients

Sorafenib (SFB) flat dose (FD) in frail elderly patients (FEPts) with Child–Pugh Advanced Hepatocellular Carcinoma (AHCC): Two year

Cancer in the older person

Assessment and treatment of elderly people with cancer: Italian (AIOM–SIGG) onco-geriatric survey results

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

A weekly regimen of cisplatin, paclitaxel and topotecan with granulocyte-colony stimulating factor support for patients with extensive disease small cell lung cancer: a phase II study

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

4017 Antiangiogenetic drugs in combination with irinotecan (IRI) and capecitabine (XEL) in ACRC elderly patients: first data about safety and efficacy

Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2–3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study

Metronomic (M), capecitabine (C), and oxaliplatin (O) plus bevacizumab (B) as treatment of advanced colorectal cancer (ACRC) in very elderly people (M-COB): Efficacy and safety (E&S) evaluation—A 2-year monitoring

Metronomic therapy irinotecan (IRI) capecitabine (CAP) plus bevacizumab (BEV) in treatment of advanced colorectal cancer (ACRC) in very elderly people

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

Impact of VEGF and CgA as new predictive tools in management of elderly hormone-refractory prostate cancer (HRPC) patients

Management of breast cancer in the older woman

Comparison between gemcitabine-based combination (G) and single-agent chemotherapy (S) for elderly patients (EP) with advanced non-small cell lung cancer (NSCLC): A literature-based meta-analysis

Efficacy and safety of a combined treatment schedule with fulvestrant (F) and capecitabine (C) in elderly advanced breast cancer patients

The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause

Efficacy of weekly low-dose chemotherapy in elderly women with advanced ovarian cancer: is there an antiangiogenic effect?

Tailored vinorelbine-capecitabine treatment in elderly metastatic breast cancer patients. A SICOG phase II study

Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG)

Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer

Neoadjuvant oxaliplatin (OXA), raltitrexed (TOM), 5- fluorouracil (FU) and folinic acid (FA) + radiotherapy followed by optimal surgery in locally advanced rectal cancer (LARC)

Suchergebnisse filtern